Tuesday, April 30, 2024 2:49:29 PM
My view point on Movano is simple. They have the resources to succeed with or without FDA approval or delay. They also have the intellectual resources to succeed as well in the industry they are endeavoring to break into. They have an excellent medical executive team. They have an excellent R&D staff. For them FDA approval would make their success easier to achieve. They are prepared to sell two product lines with approval and without approval.
I own no shares in movano.
I own no shares in movano.
Recent LQMT News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 08:37:19 PM
- Liquidmetal Technologies Inc. to Present at the LD Micro Main Event XIX • Newsfile • 10/06/2025 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2025 08:00:57 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2025 08:02:21 PM
